(Q66402389)

English

Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase II Study to Evaluate the Activity of Commercially Available Molecularly Matched Targeted Therapies in Selected Tumor Types Based on Genomic Alterations (English)

0 references

medical condition

carcinoma

0 references

country

United States of America

0 references

contributor to the creative work or subject

Foundation Medicine

0 references

start time

28 September 2016

0 references

end time

1 December 2019

0 references

number of participants

160

0 references

clinical trial phase

phase II clinical trial

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02795156

0 references

(Q66402389)

Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)